Malta, 2006: 1st Annual Pritor/Kinzal Stand Alone Symposium
(September, 2006) The Bayer HealthCare Symposium 'Pritor/Kinzal-Exceeding the ARB promise', which outlined how Pritor/Kinzal can address the current challenges in hypertension management, delivered a very comprehensive programme to more than 600 physicians from across Europe. The eminent faculty agreed that Pritor®/Kinzal® not only provides effective and sustained blood pressure control, but has additional cardiometabolic advantages.
The symposium dealt with a wide range of topics, including the future of hypertension management, the importance of managing risk factors, reasons for suboptimal blood pressure control, head-to-head comparisons of Pritor®/Kinzal® with other ARBS and other drug classes and controlling hypertension as part of a multiple-risk-factor management strategy.
-
Meeting Summary
180 KB PDF download
-
Abstract Booklet
1,5 MB PDF download
-
Press Release
Oct, 2006 - Effective 24-hr blood pressure lowering and end-organ protection
English 101 KB PDF download
